A short D-enantiomeric antimicrobial peptide with potent immunomodulatory and antibiofilm activity against multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii
Abstract Antimicrobial peptides (AMPs) represent a promising therapeutic alternative for the treatment of antibiotic-resistant bacterial infections. The present study investigates the antimicrobial activity of new, rationally-designed derivatives of a short α-helical peptide, RR. From the peptides d...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5369fd7d7b3c42f8b424b36262d3446f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:5369fd7d7b3c42f8b424b36262d3446f |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:5369fd7d7b3c42f8b424b36262d3446f2021-12-02T15:05:36ZA short D-enantiomeric antimicrobial peptide with potent immunomodulatory and antibiofilm activity against multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii10.1038/s41598-017-07440-02045-2322https://doaj.org/article/5369fd7d7b3c42f8b424b36262d3446f2017-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-07440-0https://doaj.org/toc/2045-2322Abstract Antimicrobial peptides (AMPs) represent a promising therapeutic alternative for the treatment of antibiotic-resistant bacterial infections. The present study investigates the antimicrobial activity of new, rationally-designed derivatives of a short α-helical peptide, RR. From the peptides designed, RR4 and its D-enantiomer, D-RR4, emerged as the most potent analogues with a more than 32-fold improvement in antimicrobial activity observed against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii. Remarkably, D-RR4 demonstrated potent activity against colistin-resistant strains of P. aeruginosa (isolated from cystic fibrosis patients) indicating a potential therapeutic advantage of this peptide over several AMPs. In contrast to many natural AMPs, D-RR4 retained its activity under challenging physiological conditions (high salts, serum, and acidic pH). Furthermore, D-RR4 was more capable of disrupting P. aeruginosa and A. baumannii biofilms when compared to conventional antibiotics. Of note, D-RR4 was able to bind to lipopolysaccharide to reduce the endotoxin-induced proinflammatory cytokine response in macrophages. Finally, D-RR4 protected Caenorhabditis elegans from lethal infections of P. aeruginosa and A. baumannii and enhanced the activity of colistin in vivo against colistin-resistant P. aeruginosa.Mohamed F. MohamedAnna BrezdenHaroon MohammadJean ChmielewskiMohamed N. SeleemNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-13 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Mohamed F. Mohamed Anna Brezden Haroon Mohammad Jean Chmielewski Mohamed N. Seleem A short D-enantiomeric antimicrobial peptide with potent immunomodulatory and antibiofilm activity against multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii |
description |
Abstract Antimicrobial peptides (AMPs) represent a promising therapeutic alternative for the treatment of antibiotic-resistant bacterial infections. The present study investigates the antimicrobial activity of new, rationally-designed derivatives of a short α-helical peptide, RR. From the peptides designed, RR4 and its D-enantiomer, D-RR4, emerged as the most potent analogues with a more than 32-fold improvement in antimicrobial activity observed against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii. Remarkably, D-RR4 demonstrated potent activity against colistin-resistant strains of P. aeruginosa (isolated from cystic fibrosis patients) indicating a potential therapeutic advantage of this peptide over several AMPs. In contrast to many natural AMPs, D-RR4 retained its activity under challenging physiological conditions (high salts, serum, and acidic pH). Furthermore, D-RR4 was more capable of disrupting P. aeruginosa and A. baumannii biofilms when compared to conventional antibiotics. Of note, D-RR4 was able to bind to lipopolysaccharide to reduce the endotoxin-induced proinflammatory cytokine response in macrophages. Finally, D-RR4 protected Caenorhabditis elegans from lethal infections of P. aeruginosa and A. baumannii and enhanced the activity of colistin in vivo against colistin-resistant P. aeruginosa. |
format |
article |
author |
Mohamed F. Mohamed Anna Brezden Haroon Mohammad Jean Chmielewski Mohamed N. Seleem |
author_facet |
Mohamed F. Mohamed Anna Brezden Haroon Mohammad Jean Chmielewski Mohamed N. Seleem |
author_sort |
Mohamed F. Mohamed |
title |
A short D-enantiomeric antimicrobial peptide with potent immunomodulatory and antibiofilm activity against multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii |
title_short |
A short D-enantiomeric antimicrobial peptide with potent immunomodulatory and antibiofilm activity against multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii |
title_full |
A short D-enantiomeric antimicrobial peptide with potent immunomodulatory and antibiofilm activity against multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii |
title_fullStr |
A short D-enantiomeric antimicrobial peptide with potent immunomodulatory and antibiofilm activity against multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii |
title_full_unstemmed |
A short D-enantiomeric antimicrobial peptide with potent immunomodulatory and antibiofilm activity against multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii |
title_sort |
short d-enantiomeric antimicrobial peptide with potent immunomodulatory and antibiofilm activity against multidrug-resistant pseudomonas aeruginosa and acinetobacter baumannii |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/5369fd7d7b3c42f8b424b36262d3446f |
work_keys_str_mv |
AT mohamedfmohamed ashortdenantiomericantimicrobialpeptidewithpotentimmunomodulatoryandantibiofilmactivityagainstmultidrugresistantpseudomonasaeruginosaandacinetobacterbaumannii AT annabrezden ashortdenantiomericantimicrobialpeptidewithpotentimmunomodulatoryandantibiofilmactivityagainstmultidrugresistantpseudomonasaeruginosaandacinetobacterbaumannii AT haroonmohammad ashortdenantiomericantimicrobialpeptidewithpotentimmunomodulatoryandantibiofilmactivityagainstmultidrugresistantpseudomonasaeruginosaandacinetobacterbaumannii AT jeanchmielewski ashortdenantiomericantimicrobialpeptidewithpotentimmunomodulatoryandantibiofilmactivityagainstmultidrugresistantpseudomonasaeruginosaandacinetobacterbaumannii AT mohamednseleem ashortdenantiomericantimicrobialpeptidewithpotentimmunomodulatoryandantibiofilmactivityagainstmultidrugresistantpseudomonasaeruginosaandacinetobacterbaumannii AT mohamedfmohamed shortdenantiomericantimicrobialpeptidewithpotentimmunomodulatoryandantibiofilmactivityagainstmultidrugresistantpseudomonasaeruginosaandacinetobacterbaumannii AT annabrezden shortdenantiomericantimicrobialpeptidewithpotentimmunomodulatoryandantibiofilmactivityagainstmultidrugresistantpseudomonasaeruginosaandacinetobacterbaumannii AT haroonmohammad shortdenantiomericantimicrobialpeptidewithpotentimmunomodulatoryandantibiofilmactivityagainstmultidrugresistantpseudomonasaeruginosaandacinetobacterbaumannii AT jeanchmielewski shortdenantiomericantimicrobialpeptidewithpotentimmunomodulatoryandantibiofilmactivityagainstmultidrugresistantpseudomonasaeruginosaandacinetobacterbaumannii AT mohamednseleem shortdenantiomericantimicrobialpeptidewithpotentimmunomodulatoryandantibiofilmactivityagainstmultidrugresistantpseudomonasaeruginosaandacinetobacterbaumannii |
_version_ |
1718388765001515008 |